Abstract
Background and Purpose
Sarcopenia is an age-related syndrome that is associated with poor outcomes in many disease states. In this study, we aimed to evaluate the utility of muscle biomarkers of sarcopenia in predicting clinical outcomes for patients with large vessel occlusion (LVO) acute ischemic stroke (AIS).
Methods
This was a single-center observational cohort study of consecutive patients that underwent endovascular thrombectomy (EVT) for LVO AIS. A deep-learning model was employed to segment and measure the volume, surface area, and maximum thickness of temporalis and sternocleidomastoid (SCM) muscles. The primary outcome was functional independence (FI), defined by a modified Rankin Scale of 0–2 at 3 months post-stroke. Univariable and multivariable logistic regression models were performed to evaluate associations between muscle biomarkers and outcome measures after adjusting for clinical variables of age, sex, and National Institute of Health Stroke Scale (NIHSS), and successful recanalization status which was defined as a thrombolysis in cerebral infarction scale of 2B, 2C, or 3.
Results
In total, 122 (41.1%) of 297 included patients achieved FI. For each 10 cm3 decrease in SCM volume and temporalis volume, the odds of FI decreased by 34% (odds ratios (OR) 0.66, 95% confidence interval (CI) 0.52–0.84,
Conclusions
Our study identified that temporalis and SCM muscle volumes were independently associated with functional outcomes after EVT for LVO AIS and may help to identify high-risk patients who would benefit from early post-stroke multidisciplinary management to prevent longer-term complications.
Get full access to this article
View all access options for this article.
References
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
